ProACT System (Male)
Male Stress Urinary Incontinence (SUI) post-prostatectomy
ApprovedActive
Key Facts
Indication
Male Stress Urinary Incontinence (SUI) post-prostatectomy
Phase
Approved
Status
Active
Company
About Uromedica
Uromedica is a private, commercial-stage medical device company focused on a niche but significant urological condition: stress urinary incontinence. Its core technology, the Adjustable Continence Therapy (ACT/ProACT) system, is a minimally invasive, adjustable, and reversible implant that has been used in over 16,000 patients globally. While commercially available in Europe, Canada, and Australia, the female ACT system is still under investigation in the U.S., representing a key regulatory milestone and growth opportunity. The company operates from Plymouth, Minnesota.
View full company profile